EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Barrier dysfunction in nasal epithelium contributes to persistent inflammation in long COVID

Nadia Baalbaki, Daniëlle van Egmond, Patricia Jaeger, Merel E B Cornelissen, Sien T Verbeek, Milena Sokolowska, Cornelis M van Drunen, Anke H Maitland-van der Zee, Korneliusz Golebski, P4O2 consortium

Journal of Allergy and Clinical Immunology · 2026

DOI: 10.1016/j.jaci.2025.09.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026. Verfasst von Nadia Baalbaki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Institute for Infection and Immunity,…. Hauptthemen laut MEDLINE: COVID-19, Nasal Mucosa, SARS-CoV-2, Inflammation. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health~Holland, ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Long COVID (LC) is characterized by persistent symptoms associated with chronic inflammation and immune dysregulation, but the local tissue mechanisms driving these processes remain poorly understood. OBJECTIVE: Given that the nasal epithelium is the primary entry and infection site for SARS-CoV-2, we aimed to investigate its role in LC and its potential contribution to systemic immune activation. METHODS: We analyzed nasal epithelial samples and peripheral blood from participants in the Precision Medicine for More Oxygen (P4O2) COVID-19 cohort, post-COVID-19 individuals, and healthy controls. We assessed epithelial barrier integrity, evaluated wound healing, and explored cytokine profiles. Transcriptomic analysis was performed via RNA sequencing. Blood innate lymphoid cells (ILCs) were phenotyped by flow cytometry and stimulated in vitro for functional assays. RESULTS: Among a subgroup of LC patients, nasal epithelial cells showed impaired barrier function, reduced expression of ZO-1 and occludin and exaggerated sensitivity to viral triggers. Despite faster wound closure, the epithelial repair was reduced. The LC nasal epithelium exhibited increased cytokine production, including IL-1β and transcriptomic signatures of inflammation, including upregulation of interferon pathways. Furthermore, we found that TFs ATF3 and EGR1 were downregulated in LC. Elevated IL-1β levels in nasal epithelium promoted ILC activation and plasticity toward IFN-γ-producing ILCs in blood. CONCLUSION: While multiple organ systems are implicated in LC, our findings identified nasal epithelial dysfunction in a subgroup of LC patients and chronic activation as potential contributors to systemic immune dysregulation. The IL-1β-IFN-γ axis represents a novel targetable pathway that may support precision therapies for LC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Nasal MucosaSARS-CoV-2InflammationHumansMaleFemaleMiddle AgedCytokinesAdultAgedLymphocytes

Stichwörter der Autor:innen

Long COVIDepithelial barrier dysfunctionepithelial-immune cross talkpostviral conditionprecision medicine

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands; Amsterdam Public Health, Amsterdam, The N…
  • Department of Otorhinolaryngology/Head-Neck Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands; Department of Otorhinolaryngology/Head-Ne…
  • Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland.

Förderung

  • Health~Holland
  • ZonMw

Zitieren

APA

Baalbaki, N., van Egmond, D., Jaeger, P., Cornelissen, M. E. B., Verbeek, S. T., Sokolowska, M., van Drunen, C. M., Maitland-van der Zee, A. H., Golebski, K., & P4O2 consortium (2026). Barrier dysfunction in nasal epithelium contributes to persistent inflammation in long COVID. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.09.024

Vancouver

Baalbaki N, van Egmond D, Jaeger P, Cornelissen MEB, Verbeek ST, Sokolowska M, et al. Barrier dysfunction in nasal epithelium contributes to persistent inflammation in long COVID. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2025.09.024

BibTeX
@article{Baalbaki2026,
  author = {Baalbaki, Nadia and van Egmond, Daniëlle and Jaeger, Patricia and Cornelissen, Merel E B and Verbeek, Sien T and Sokolowska, Milena and van Drunen, Cornelis M and Maitland-van der Zee, Anke H and Golebski, Korneliusz and P4O2 consortium, P4O2 consortium},
  title = {Barrier dysfunction in nasal epithelium contributes to persistent inflammation in long COVID},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  doi = {10.1016/j.jaci.2025.09.024}
}
Kostenlos starten →